Dr. Carlos Eduardo Silva Correia
Claim this profileJersey Shore Medical Center
Studies Glioblastoma
Studies Brain Tumor
5 reported clinical trials
13 drugs studied
Area of expertise
1Glioblastoma
MET positive
IDH negative
MET negative
2Brain Tumor
IDH positive
1p/19q co-deletion positive
Stage IV
Affiliated Hospitals
Clinical Trials Carlos Eduardo Silva Correia is currently running
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. Chemotherapy drugs, such as lomustine and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy photons to kill tumor cells and shrink tumors. Adding lomustine to usual treatment of temozolomide and radiation therapy may help shrink and stabilize glioblastoma.
Recruiting2 awards Phase 34 criteria
Targeted Therapy
for Brain Cancer
This phase II trial studies how well genetic testing works in guiding treatment for patients with solid tumors that have spread to the brain. Several genes have been found to be altered or mutated in brain metastases such as NTRK, ROS1, CDK, PI3K, or KRAS G12C. Medications that target these genes such as abemaciclib, paxalisib, entrectinib and adagrasib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Genetic testing may help doctors tailor treatment for each mutation.
Recruiting1 award Phase 217 criteria
More about Carlos Eduardo Silva Correia
Clinical Trial Related2 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Carlos Eduardo Silva Correia has experience with
- Temozolomide
- Atezolizumab
- Tocilizumab
- Fractionated Stereotactic Radiation Therapy
- Lomustine
- Photon Beam Radiation Therapy
Breakdown of trials Carlos Eduardo Silva Correia has run
Glioblastoma
Brain Tumor
Astrocytoma
Diffuse Astrocytoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Carlos Eduardo Silva Correia specialize in?
Carlos Eduardo Silva Correia focuses on Glioblastoma and Brain Tumor. In particular, much of their work with Glioblastoma has involved MET positive patients, or patients who are IDH negative.
Is Carlos Eduardo Silva Correia currently recruiting for clinical trials?
Yes, Carlos Eduardo Silva Correia is currently recruiting for 4 clinical trials in Neptune New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Carlos Eduardo Silva Correia has studied deeply?
Yes, Carlos Eduardo Silva Correia has studied treatments such as Temozolomide, Atezolizumab, Tocilizumab.
What is the best way to schedule an appointment with Carlos Eduardo Silva Correia?
Apply for one of the trials that Carlos Eduardo Silva Correia is conducting.
What is the office address of Carlos Eduardo Silva Correia?
The office of Carlos Eduardo Silva Correia is located at: Jersey Shore Medical Center, Neptune, New Jersey 07753 United States. This is the address for their practice at the Jersey Shore Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.